Oxaliplatin-safety profile: neurotoxicity
- PMID: 14523789
- DOI: 10.1016/s0093-7754(03)00399-3
Oxaliplatin-safety profile: neurotoxicity
Abstract
Oxaliplatin has become an integral part of various chemotherapy protocols, and in advanced colorectal cancer in particular. While oxaliplatin has only mild hematologic and gastrointestinal side effects, its dose-limiting toxicity is a cumulative sensory neurotoxicity that resembles that of cisplatin with the important difference of a more rapid and complete reversibility. The reversibility of neurotoxicity has been assured in long-term follow-up of patients who have received adjuvant oxaliplatin-based chemotherapy. In addition, oxaliplatin causes a very unique, but frequent, acute sensory neuropathy that is triggered or aggravated by exposure to cold but is rapidly reversible, without persistent impairment of sensory function. Various strategies have been proposed to prevent or treat oxaliplatin-induced neurotoxicity. The "Stop-and-Go" concept uses the reversibility of neurologic symptoms to aim at delivering higher cumulative oxaliplatin doses as long as the therapy is still effective. Several neuromodulatory agents such as calcium-magnesium infusions, antiepileptic drugs like carbamazepine or gabapentin, amifostine, alpha-lipoic acid, and glutathione have shown promising activity in prophylaxis and treatment of oxaliplatin-induced neurotoxicity. However, larger confirmatory trials are still lacking so that, to date, no evidence-based recommendation can be given for the prophylaxis of oxaliplatin-induced neurotoxicity. The predictability of neurotoxicity associated with oxaliplatin-based therapy should allow patients and doctors to develop strategies to manage this side effect in view of the individual patient's clinical situation.
Similar articles
-
Clinical management of oxaliplatin-associated neurotoxicity.Clin Colorectal Cancer. 2005 Apr;5 Suppl 1:S38-46. doi: 10.3816/ccc.2005.s.006. Clin Colorectal Cancer. 2005. PMID: 15871765 Review.
-
Oral Calcium Ameliorating Oxaliplatin-Induced Peripheral Neuropathy.J Appl Res. 2004 Jan 1;4(4):576-582. J Appl Res. 2004. PMID: 19816592 Free PMC article.
-
Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.Clin Colorectal Cancer. 2002 May;2(1):54-8. doi: 10.3816/CCC.2002.n.011. Clin Colorectal Cancer. 2002. PMID: 12453338
-
[Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study].Dtsch Med Wochenschr. 2002 Jan 18;127(3):78-82. doi: 10.1055/s-2002-19594. Dtsch Med Wochenschr. 2002. PMID: 11797144 German.
-
Oxaliplatin-associated neuropathy: a review.Ann Pharmacother. 2005 Jan;39(1):128-35. doi: 10.1345/aph.1E319. Epub 2004 Dec 8. Ann Pharmacother. 2005. PMID: 15590869 Review.
Cited by
-
Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy.Med Oncol. 2011 Jun;28(2):488-93. doi: 10.1007/s12032-010-9487-2. Epub 2010 Mar 31. Med Oncol. 2011. PMID: 20354823
-
Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients.BMC Cancer. 2013 Oct 25;13:495. doi: 10.1186/1471-2407-13-495. BMC Cancer. 2013. PMID: 24156389 Free PMC article. Clinical Trial.
-
Long-term platinum retention after treatment with cisplatin and oxaliplatin.BMC Clin Pharmacol. 2008 Sep 17;8:7. doi: 10.1186/1472-6904-8-7. BMC Clin Pharmacol. 2008. PMID: 18796166 Free PMC article. Clinical Trial.
-
Postoperative Adjuvant Chemotherapy Regimen of CAPOX Combined With Ninjin'yoeito in an Elderly Patient With Stage III Colon Cancer: A Case Report.Front Nutr. 2020 Apr 30;7:57. doi: 10.3389/fnut.2020.00057. eCollection 2020. Front Nutr. 2020. PMID: 32426365 Free PMC article.
-
Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study.BMC Cancer. 2021 Aug 30;21(1):974. doi: 10.1186/s12885-021-08717-4. BMC Cancer. 2021. PMID: 34461860 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical